SCHEMBL2070772

SCHEMBL2070772

CCOC1OC(=O)C(CC)C(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9524067 0.87
SCHEMBL13659733 0.72
SCHEMBL1543389 0.71 CYP1A2 (0.32)
SCHEMBL15337522 0.69
Ethylene SCHEMBL28641046 0.68 CYP1A2 (0.31)
SCHEMBL321303 0.68 LMNA (0.32)
SCHEMBL10339691 0.67
SCHEMBL28952671 0.65
SCHEMBL28635931 0.64
SCHEMBL5924204 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0267432-B1 ANTIBACTERIALLY ACTIVE PYRIDO-BENZOTHIAZINE DERIVATIVES WITH LONG TERM ACTION MEDIOLANUM FARMACEUTICI s.r.l. (IT) 1991-12-27 EP claimed
US-4868299-A Antibacterially active pyrido-benzothiazine derivatives with long-term action MEDIOLANUM FARMACEUTICI SRL (IT) 1989-09-19 US claimed
EP-0267432-A1 Antibacterially active pyrido-benzothiazine derivatives with long term action MEDIOLANUM FARMACEUTICI s.r.l. (IT) 1988-05-18 EP claimed
EP-2522670-A1 Heterocyclic CRF receptor antagonists Takeda Pharmaceutical Company Limited (JP) 2012-11-14 EP disclosed
US-7897607-B2 Cyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-01 US disclosed
EP-1732541-A4 CYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2008-03-05 EP disclosed
US-20070179165-A1 Cyclic compounds GYORKOS ALBERT C 2007-08-02 US disclosed
WO-2007026215-A1 PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING? THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2007-03-08 WO disclosed
EP-1732541-A2 CYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2006-12-20 EP disclosed
WO-2005099688-A2 CYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-10-27 WO disclosed
EP-1419155-A2 PIPERIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2004-05-19 EP disclosed
WO-2003010138-A2 PIPERIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2003-02-06 WO disclosed
US-6465653-B2 HEATING AND HYDROLYZING/DECARBOXYLATING 4-HYDROXYQUINOLINE CARBOXYLIC ACID ESTER IN PRESENCE OF WATER IN LIQUID OR VAPOR PHASE; PLANT SAFENING AGENTS RHODIA CHIMIE (FR) 2002-10-15 US disclosed
US-20020007067-A1 Noncatalyzed synthesis of 4-hydroxyquinolines and/or tautomers thereof RHODIA CHIMIE (FR) 2002-01-17 US disclosed
WO-1996040138-A1 CHLOROQUINE ANALOGS AND METHODS OF PREVENTING AND TREATING PLASMODIAL DISEASE THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1996-12-19 WO disclosed
US-4868299-A Antibacterially active pyrido-benzothiazine derivatives with long-term action MEDIOLANUM FARMACEUTICI SRL (IT) 1989-09-19 US disclosed
US-4450166-A N-(4,5-Dihydro-thiazol-2-yl)-3-quinoline-carboxamides having anxiolytic activity ROUSSEL UCLAF (FR) 1984-05-22 US disclosed
US-4277607-A Process for the preparation of 4-chloroquinolines ROUSSEL UCLAF (FR) 1981-07-07 US disclosed
US-4250178-A NEUROLEPTIC AGENTS DELALANDE S.A. (FR) 1981-02-10 US disclosed
US-4190661-A BACTERICIDES LABORATOIRES CHAUVIN-BLACHE (FR) 1980-02-26 US disclosed